HUE030282T2 - A method for preparing the crystalline Form I of agomelatine - Google Patents
A method for preparing the crystalline Form I of agomelatine Download PDFInfo
- Publication number
- HUE030282T2 HUE030282T2 HUE11770507A HUE11770507A HUE030282T2 HU E030282 T2 HUE030282 T2 HU E030282T2 HU E11770507 A HUE11770507 A HU E11770507A HU E11770507 A HUE11770507 A HU E11770507A HU E030282 T2 HUE030282 T2 HU E030282T2
- Authority
- HU
- Hungary
- Prior art keywords
- agomelatine
- solution
- solvent
- freeze
- crystalline form
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 32
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title description 48
- 229960002629 agomelatine Drugs 0.000 title description 45
- 238000002360 preparation method Methods 0.000 title description 10
- 239000002904 solvent Substances 0.000 claims description 24
- 241000282994 Cervidae Species 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 33
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 18
- 238000004108 freeze drying Methods 0.000 description 15
- 239000003960 organic solvent Substances 0.000 description 11
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000000859 sublimation Methods 0.000 description 3
- 230000008022 sublimation Effects 0.000 description 3
- YXDUMIVUPSVYLB-UHFFFAOYSA-N 2-(7-methoxynaphthalen-1-yl)ethanamine Chemical compound C1=CC=C(CCN)C2=CC(OC)=CC=C21 YXDUMIVUPSVYLB-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000005092 sublimation method Methods 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012926 crystallographic analysis Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Battery Electrode And Active Subsutance (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2011/001805 WO2013017903A1 (en) | 2011-08-03 | 2011-08-03 | Process for the preparation of crystalline form i of agomelatine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE030282T2 true HUE030282T2 (en) | 2017-05-29 |
Family
ID=44802320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE11770507A HUE030282T2 (en) | 2011-08-03 | 2011-08-03 | A method for preparing the crystalline Form I of agomelatine |
Country Status (16)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104876830A (zh) * | 2015-06-09 | 2015-09-02 | 江苏中邦制药有限公司 | 一种阿戈美拉汀i晶型晶体的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2866335B1 (fr) | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
| EP2319827A1 (en) * | 2009-11-09 | 2011-05-11 | Ratiopharm GmbH | Process for the production of polymorph form I of agomelatine |
| CN101704763B (zh) | 2009-11-25 | 2012-03-28 | 天津泰普药品科技发展有限公司 | 阿戈美拉汀i型晶体的制备方法 |
| CN101921205B (zh) * | 2010-08-30 | 2013-11-20 | 江苏恩华药业股份有限公司 | 阿戈美拉汀ⅰ晶型的制备方法 |
-
2011
- 2011-08-03 CN CN201180072630.4A patent/CN103827078B/zh not_active Expired - Fee Related
- 2011-08-03 ES ES11770507.9T patent/ES2577177T3/es active Active
- 2011-08-03 IN IN348CHN2014 patent/IN2014CN00348A/en unknown
- 2011-08-03 HR HRP20160767TT patent/HRP20160767T1/hr unknown
- 2011-08-03 CA CA2843827A patent/CA2843827A1/en not_active Abandoned
- 2011-08-03 DK DK11770507.9T patent/DK2739605T3/en active
- 2011-08-03 HU HUE11770507A patent/HUE030282T2/en unknown
- 2011-08-03 PT PT117705079T patent/PT2739605E/pt unknown
- 2011-08-03 PL PL11770507.9T patent/PL2739605T3/pl unknown
- 2011-08-03 WO PCT/IB2011/001805 patent/WO2013017903A1/en active Application Filing
- 2011-08-03 EP EP11770507.9A patent/EP2739605B1/en not_active Not-in-force
- 2011-08-03 SI SI201130880A patent/SI2739605T1/sl unknown
- 2011-08-03 US US14/236,772 patent/US20150291508A1/en not_active Abandoned
- 2011-08-03 EA EA201400188A patent/EA024650B1/ru not_active IP Right Cessation
- 2011-08-03 BR BR112014002523A patent/BR112014002523A2/pt not_active Application Discontinuation
-
2016
- 2016-07-20 CY CY20161100712T patent/CY1117823T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103827078A (zh) | 2014-05-28 |
| CY1117823T1 (el) | 2017-05-17 |
| PL2739605T3 (pl) | 2016-11-30 |
| IN2014CN00348A (enrdf_load_stackoverflow) | 2015-04-03 |
| EP2739605A1 (en) | 2014-06-11 |
| EA024650B1 (ru) | 2016-10-31 |
| WO2013017903A1 (en) | 2013-02-07 |
| SI2739605T1 (sl) | 2016-08-31 |
| US20150291508A1 (en) | 2015-10-15 |
| EP2739605B1 (en) | 2016-04-27 |
| PT2739605E (pt) | 2016-06-20 |
| CA2843827A1 (en) | 2013-02-07 |
| ES2577177T3 (es) | 2016-07-13 |
| HRP20160767T1 (hr) | 2016-08-12 |
| BR112014002523A2 (pt) | 2017-03-14 |
| DK2739605T3 (en) | 2016-07-25 |
| CN103827078B (zh) | 2015-08-05 |
| EA201400188A1 (ru) | 2014-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1572635B1 (fr) | Procede de preparation et formes cristallines des enantiomeres optiques du modafinil | |
| CA2102457C (fr) | Derives de l'erythromycine, leur procede de preparation, leur application comme medicaments | |
| WO2002034713A1 (fr) | Procede de production de cristaux de nateglinide a forme b | |
| EP0913374B1 (fr) | Procédé d'obtention de la forme polymorphe epsilon de l'hexanitrohexaazaisowurtzitane | |
| CA2764603C (en) | Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid by poor-solvent addition method | |
| EP0001024B1 (fr) | Forme cristalline du sel de sodium d'un dérivé oximiné de l'acide 7-amino thiazolyl acétamido céphalosporanique, son procédé de préparation et les compositions pharmaceutiques la renfermant | |
| HUE029847T2 (en) | Optimized synthesis of pure non-polymorphic bile acids having a defined particle size | |
| HUE030282T2 (en) | A method for preparing the crystalline Form I of agomelatine | |
| DE102012005219B4 (de) | Verfahren zur Isomerisierung von Alkenen | |
| TW201035028A (en) | Process for the preparation of optically active compounds using transfer hydrogenation | |
| CH627648A5 (fr) | Nouveaux derives de 20,21-dinoreburnamenine, procede de preparation et compositions pharmaceutiques. | |
| EP1803714A1 (en) | Process for preparing crystalline forms of orlistat | |
| EP3053919B1 (en) | Crystalline form of 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and preparation method thereof | |
| JP7531767B2 (ja) | セラミドの製造方法 | |
| CN114369134B (zh) | 一种Lupane三萜系衍生物葡甲胺盐无定型物及其制备方法和应用 | |
| CN101489987A (zh) | 四环素衍生物的分离 | |
| BR112020004217A2 (pt) | processo para o preparo de citrato de ixazomibe | |
| RU2787769C1 (ru) | Способ получения малотоксичного n-2-гидроксифенилметилен-41-(7-циклогепта-1,3,5-триенил)анилина | |
| JP2004231598A (ja) | メシル酸ナファモスタットの結晶多形及びその製造方法 | |
| US9024068B2 (en) | Process for the preparation of crystalline forms of agomelatine and novel polymorph thereof | |
| JP5419570B2 (ja) | ２−アセチルアミノメチル−４−（４−フルオロベンジル）モルホリンの精製方法 | |
| CN108373437A (zh) | 一种阿托伐他汀钙异构体的制备方法 | |
| JPH06279435A (ja) | ラクタイドの精製方法 | |
| RU2678093C1 (ru) | Способ получения бензилдиметил[3-(миристоиламино)-пропил]аммонийхлорида моногидрата и фармацевтической субстанции на его основе | |
| BE569202A (enrdf_load_stackoverflow) |